Expression analysis of endoglin missense and truncation mutations: insights into protein structure and disease mechanisms
- PMID: 10749981
- DOI: 10.1093/hmg/9.5.745
Expression analysis of endoglin missense and truncation mutations: insights into protein structure and disease mechanisms
Abstract
Hereditary hemorrhagic telangiectasia (HHT) is an inherited autosomal dominant vascular dysplasia caused by mutations in either endoglin (HHT1) or activin-like kinase receptor-1 (ALK-1) (HHT2). The majority of the mutations in endoglin cause frameshifts and premature stop codons. Although initial reports suggested a dominant-negative model for HHT1, more recent reports have suggested that mutations in endoglin lead to haploinsufficiency. In this study, we investigated six different missense mutations and two truncation mutations in the endoglin gene to examine whether mechanisms other than haploinsufficiency might be involved in HHT1. Expression of the missense mutants alone revealed that they are misfolded and that most show no cell surface expression. When co-expressed with wild-type endoglin, the missense mutants are able to dimerize with the normal endoglin protein and are trafficked to the cell surface. We also show that although one truncation mutation acts through haploinsufficiency, the other acts in a dominant-negative way. This implies that either dominant-negative protein interactions or haploinsufficiency can cause HHT1. The biochemical analyses for the different mutations suggest that the endoglin N-terminus is important for correct protein folding and that cysteine residues in the first 350 amino acids are involved in intramolecular disulfide bonds, whereas cysteines located closer to the C-terminus of the extracellular domain are responsible for inter-molecular disulfide bond dimerization.
Similar articles
-
Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type 1.Hum Mol Genet. 1999 Nov;8(12):2171-81. doi: 10.1093/hmg/8.12.2171. Hum Mol Genet. 1999. PMID: 10545596
-
Analysis of several endoglin mutants reveals no endogenous mature or secreted protein capable of interfering with normal endoglin function.Hum Mol Genet. 2001 Jun 15;10(13):1347-57. doi: 10.1093/hmg/10.13.1347. Hum Mol Genet. 2001. PMID: 11440987
-
Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2.Hum Mol Genet. 2000 May 1;9(8):1227-37. doi: 10.1093/hmg/9.8.1227. Hum Mol Genet. 2000. PMID: 10767348
-
Endoglin-deficient mice, a unique model to study hereditary hemorrhagic telangiectasia.Trends Cardiovasc Med. 2000 Oct;10(7):279-85. doi: 10.1016/s1050-1738(01)00062-7. Trends Cardiovasc Med. 2000. PMID: 11343967 Review.
-
Genetic and molecular pathogenesis of hereditary hemorrhagic telangiectasia.J Med Invest. 2000 Aug;47(3-4):81-90. J Med Invest. 2000. PMID: 11019486 Review.
Cited by
-
Blood flow regulates acvrl1 transcription via ligand-dependent Alk1 activity.bioRxiv [Preprint]. 2024 Jan 25:2024.01.25.576046. doi: 10.1101/2024.01.25.576046. bioRxiv. 2024. PMID: 38328175 Free PMC article. Preprint.
-
Endoglin Wild Type and Variants Associated With Hereditary Hemorrhagic Telangiectasia Type 1 Undergo Distinct Cellular Degradation Pathways.Front Mol Biosci. 2022 Feb 25;9:828199. doi: 10.3389/fmolb.2022.828199. eCollection 2022. Front Mol Biosci. 2022. PMID: 35281255 Free PMC article.
-
Endoglin in the Spotlight to Treat Cancer.Int J Mol Sci. 2021 Mar 20;22(6):3186. doi: 10.3390/ijms22063186. Int J Mol Sci. 2021. PMID: 33804796 Free PMC article. Review.
-
Endoglin: An 'Accessory' Receptor Regulating Blood Cell Development and Inflammation.Int J Mol Sci. 2020 Dec 3;21(23):9247. doi: 10.3390/ijms21239247. Int J Mol Sci. 2020. PMID: 33287465 Free PMC article. Review.
-
Role of glycosylation in TGF-β signaling and epithelial-to-mesenchymal transition in cancer.Protein Cell. 2021 Feb;12(2):89-106. doi: 10.1007/s13238-020-00741-7. Epub 2020 Jun 25. Protein Cell. 2021. PMID: 32583064 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
